Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells.

Hu, Xiaoyan; Li, Lin; Nkwocha, Jewel; Sharma, Kanika; Zhou, Liang; Grant, Steven

Hu, Xiaoyan; Li, Lin; Nkwocha, Jewel; Sharma, Kanika; Zhou, Liang; Grant, Steven.

Afiliación

Hu X; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Li L; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Nkwocha J; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Sharma K; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Zhou L; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Grant S; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.

Hematol Rep ; 15(1): 91-100, 2023 Feb 02.

Article en En | MEDLINE | ID: mdl-36810553

Palabras clave

ABT-199/venetoclax; ROS; T-dCyd; myelodysplastic syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Hematol Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google